Ul

OTC products · Product label record

Ultra Fine Mist Sinus Relief drug information

OXYMETAZOLINE HYDROCHLORIDE
DOLGENCORP, INC. · NASAL

Product NDC: 55910-627

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameOXYMETAZOLINE HYDROCHLORIDE
Labeler / manufacturerDOLGENCORP, INC.
RouteNASAL
Drug classDrug class not supplied in source label
Product NDC55910-627
Label effective date2026-09-03

Official product label reference

Ultra Fine Mist Sinus Relief — DOLGENCORP, INC.

This page contains 14 source sections for OXYMETAZOLINE HYDROCHLORIDE, nasal route. Label set 5f134840-2465-4585-a85d-08d746f76f7a, version 7.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Uses temporarily relieves ▪ nasal congestion due to a cold, heavy fever, or other upper respiratory allergies ▪ sinus congestion and pressure

Purpose

Purpose Nasal Decongestant
Dosage and administration — label text
Directions ▪ adults & children 6 to under 12 years of age & older (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period. ▪ children 2 to under 6 years: ask a doctor ▪ children 2 years: do not use To Use: Shake well before use . Push down cap while turning counter-clockwise and remove cap . Remove clip under rim. Before using the first time, prime metered pump by depressing pump firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without titling head, insert nozzle into nostril. Fully depress rim with a firm, even stroke and sniff deeply. Wipe nozzle clean after use. Replace clip under rim and secure cap after use.
Warnings
Warnings
Active ingredient
Active ingredient Oxymetazoline hydrochloride 0.05%
Ask a doctor before use
Ask a doctor before use if you have ▪ heart disease ▪ high blood pressure ▪ diabetes ▪ thyroid disease ▪ trouble urinating due to an enlarged prostate gland
While using this medicine
When using this product ▪ do not exceed recommended dosage ▪ do not use this product for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen. ▪ temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur ▪ use of this container by more than one person may spread infection
When to stop use and seek help
Stop use and ask a doctor if • symptoms persist
Pregnancy or breast feeding
If pregnant or breast-feeding, ask a health professional before use.
Child safety
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away at (1-800-222-1222).
Storage and handling
Other information ▪ store at room temperature
Inactive ingredient
Inactive ingredients benzalkonium chloride, benzyl alcohol, camphor, edetate disodium, eucalyptol, menthol, polysorbate 80, propylene glycol, purified water, sodium phosphate dibasic, sodium phosphate monobasic.
Questions
Questions or comments? 1-866-467-2748
Package label principal display panel
Table text from source: | IMPORTANT: Keep the carton for future reference on full labeling

Official sources and product identifiers

Substances listed: OXYMETAZOLINE HYDROCHLORIDE

RxNorm identifiers: 1000990

Package NDC codes

55910-627-30

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.